MedTrace Logo

Ultrafiltration on Coagulation Performance in Cardiac Surgery

NCT05252559 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2022-06-10

No results posted yet for this study

Summary

In cardiac surgery patients with CPB-induced dilutional coagulopathy, ultrafiltration (UF) was applied to reduce free water and concentrate all blood components before the weaning from CPB. The impact of UF on the clot strength is determined by analyzing the changes of maximal clot formation in EXTEM assay (MCF-EXTEM) in the ROTEM test in patients who underwent elective cardiac valve surgery in KUMC.

Conditions

  • Cardiac Valve Disease

Interventions

PROCEDURE

ultrafiltration

In cardiac surgery patients, ultrafiltration is usually applied to reduce free water and concentrate all blood components before weaning from cardiopulmonary bypass

DIAGNOSTIC_TEST

maximal clot firmness in EXTEM assay of ROTEM test

before and after applying ultrafiltration, arterial blood sample underwent EXTEM and FIBTEM assays of rotational thromboelastometry

Sponsors & Collaborators

  • Konkuk University Medical Center

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-05-01
Completion
2022-06-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05252559 on ClinicalTrials.gov